Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ACRV
LNSR
Add up to 3 more stocks
ACRV
Acrivon Therapeutics, Inc. Common Stock
-6.06%
$1.86-0.12Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$79.61M
52W Range
$1.27 - $3.56
LNSR
LENSAR Inc
+0.45%
$6.70+0.03Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$82.29M
52W Range
$4.95 - $12.94
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.92 | 5.52 |
| P/S Ratio | N/A | 1.37 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 48.0% |
| Operating Margin | 0.0% | -42.1% |
| Net Margin | 0.0% | 57.6% |
| ROE | -85.7% | 232.8% |
| ROA | -74.9% | 49.9% |
| ROIC | -88.3% | -16.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 7.99 | 2.39 |
| Quick Ratio | 7.99 | 1.13 |
| Debt/Equity | 0.02 | 0.16 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.